ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "IASLC Lung Cancer Considered: FDA Approval: Subcutaneous Immunotherapy"
Episode Synopsis
This episode of Lung Cancer Considered reviews new and upcoming approvals for subcutaneous immune checkpoint inhibitors. Join host Dr. Narjust Florez and guests, Dr. Cheryl Ho and Dr. Maria Velez Velez, for a discussion of the formulation and its place in the management of patients with lung cancer.
Guests:
Cheryl Ho, MD, FRCPC
Thoracic Oncologist, BC Cancer
Clinical Associate Professor and Fellowship Program Director
University of British Columbia
Maria Velez Velez, MD, MS
Clinical Instructor, Division of Hematology/Oncology
David Geffen School of Medicine at UCLA
Guests:
Cheryl Ho, MD, FRCPC
Thoracic Oncologist, BC Cancer
Clinical Associate Professor and Fellowship Program Director
University of British Columbia
Maria Velez Velez, MD, MS
Clinical Instructor, Division of Hematology/Oncology
David Geffen School of Medicine at UCLA
More episodes of the podcast Lung Cancer Considered
LCC in Greek: WCLC 2025 Highlights
10/10/2025
LCC in Arabic: WCLC 2025 Highlights
03/10/2025
Lung Cancer Considered: Targeting EGFR NSCLC
03/10/2025
LCC in Korean: WCLC 2025 Highlights
30/09/2025
LCC in Portuguese: WCLC 2025 Highlights
16/09/2025
LCC in Hebrew: WCLC 2025 Highlights
10/09/2025
In God we trust